Greenville Health System ITOR - Cancer Institute — Greenville, South Carolina

Greenville Health System ITOR - Cancer Institute is a clinical research site located in Greenville, South Carolina, United States 29615.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Greenville Health System ITOR - Cancer Institute has participated in 1 clinical trials.

Therapeutic areas: Tumors With CDK4/6 Pathway Activation.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Greenville Health System ITOR - Cancer Institute?

Greenville Health System ITOR - Cancer Institute has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Greenville Health System ITOR - Cancer Institute conducted?

Greenville Health System ITOR - Cancer Institute has 1 clinical trials on record. Their work covers Tumors With CDK4/6 Pathway Activation.

Is Greenville Health System ITOR - Cancer Institute accredited by Crixeo Health?

Greenville Health System ITOR - Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Greenville Health System ITOR - Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.